Navigation Links
Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR

rom the "Technology" section of the company's website at www.seattlegenetics.com.

About Seattle Genetics

Seattle Genetics is a biotechnology company developing monoclonal antibody-based therapies for the treatment of multiple types of cancer, including lymphoma, multiple myeloma, leukemia and solid tumors. The company has an exclusive worldwide license agreement with Genentech to develop and commercialize SGN-40. Seattle Genetics also has three other proprietary programs in ongoing clinical trials: SGN-33, SGN-35 and SGN-30. In addition, the company has developed proprietary antibody-drug conjugate (ADC) technology comprised of highly potent synthetic drugs and stable linkers for attaching the drugs to monoclonal antibodies. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Genentech, Bayer, CuraGen, Progenics and MedImmune, as well as an ADC co-development agreement with Agensys. More information can be found at www.seattlegenetics.com.

Certain of the statements made in this press release are forward-looking, such as those, among others, relating to the potential therapeutic potential of Seattle Genetics' product candidates and ADC technology. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include risks related to adverse clinical results as our product candidates move into and advance in clinical trials, risks inherent in early stage development and failure by Seattle Genetics' collaborators to advance product candidates incorporating its technology. More information about the risks and uncertainties faced by Seattle Genetics is contained in Seattle Genetics' filings with the Securities and Exchange Commission. Seattle Genetics disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
2. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
3. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
4. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
5. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
6. Myriad Genetics Presents Tumor Origin Technology at AACR
7. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
8. Myriad Genetics Presents Azixas Mode of Action at AACR
9. Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

Post Your Comments:
(Date:11/6/2009)... 6 With his proposed health care r...hts on cutting name-brand prescription drug costs ...the "Part D" coverage gap, universally known as th...ntial cost-cutting and feel it,s a promising start...ful lobbyists want a revised program that complete...
(Date:11/6/2009)...ire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin...anta-based, biopharmaceutical company developing h...Immunodeficiency Virus) and other infectious agent...l results and provided an operational update. ,...tive Officer commented, "We are pleased with our p...
(Date:11/5/2009)... Osteotech, Inc. (Nasdaq:...ic products for regenerative healing, today report...eptember 30, 2009. ,, "During the third quarter...e new biologic products MagniFuse(TM) Bone Graft,...; Innovative Grafting," said Sam Owusu-Akyaw, Pres...
Breaking Medicine Technology:Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3New AMA Ad Emphasizes Common Ground on Health Reform Shares Vision to Fix Broken System 52955 1New AMA Ad Emphasizes Common Ground on Health Reform Shares Vision to Fix Broken System 52955 2HOWARU 28R 29 Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 52951 1HOWARU 28R 29 Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 52951 2
...--Mar 12, 2007 - Ceragenix Pharmaceuticals,Inc. (...n,infectious disease and dermatology, today announ...und demonstrated virtually no biofilm,formation in...ters treated with Ceragenins,were soaked daily in ...ted catheter. At day 21, the catheters were challe...
...RE)--Mar 12, 2007 - GenoMed (OTC Pink,Sheets:GMED)...hose,business is public health(TM), announced toda...tient whose pain has disappeared for,over a year t...ddle-aged African American woman who for,years req...e pain,of her sickle cell disease. Since beginning...
Other Medicine Technology:Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3GenoMed Prevents Sickle Cell Pain for Over a Year 2
(Date:11/8/2009)... 3961 to Secure the Stability of Medicare ,, H...t Attributable to: J. James Rohack, M.D., Presiden...tp://www.newscom.com/cgi-bin/prnh/20081209/AMALOGO... health reform bill, which will help improve the h... for swift passage of H.R. 3961 to secure the stab...
(Date:11/8/2009)...ealth Care Reform Bill ,, Critical legislatio...all Americans ,, BALTIMORE, Nov. 7 /PRNewswire...es House of Representatives passed critical health...icare for seniors and end discrimination by insura...t of affordable health coverage. ,, The Afforda...
(Date:11/7/2009)...ewswire/ -- The American Medical Association (AMA)...tizenship and Community Service to Manus C. Kraff,...ard recognizes physicians who have gone above and ...outstanding public service contribution to their l... during the opening session of the 2009 Interim Me...
(Date:11/7/2009)...wswire/ -- Members of the AMA are trying a last-mi...escinding the AMA,s support of HR 3962. ,, "We...le to their PATIENTS, not the leadership of the AM...e Association of American Physicians and Surgeons,...cal groups. ,, "If the AMA leadership ignores ...
(Date:11/7/2009)...SNewswire/ -- Speaker Nancy Pelosi and Democratic ...ollowing a Democratic Whip meeting with President ...eaker,s opening remarks: ,, "Thank you very mu... to receive the President of the United States on ...ote and making progress for the American people. ...
Breaking Medicine News(10 mins):Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2
...sts that maternal intake of food allergens is an i...olic among breastfed infants. Infantile colic a... life//. Colic symptoms usually peak at 6 weeks of...lled trial of a low-allergen maternal diet was con...
... choice of drug for patients suffering from prosta...ose this drug as the Scottish Medicines Consortium...ive and it does not have much effect on prostate c...cing tumor burden in these patients and has defini...
...li girl Samah Gadban lay in bed at Schneider Child...Tikvah, her mother seated by her bed holding her h... once belonged to a Palestinian boy//. At the...un he carried for a real rifle. Ahmed was tra...
...pulation-based Swedish study, Women's Health in th...mium exposure. Analysis of the data collected now ... low-level cadmium exposure [EHP 113:1627-1631]//....nic exposure through smoking and from dietary sour...
... Can reading a palm help in diagnosing health ai...anan a palmist believes palmistry is a pure scienc...ion but he reads people's palms and predicts their...n can accurately predict the ailments afflicting t...
...that in Children with neurological or neuromuscul...espiratory failure ,if they're hospitalized with i...ed in this week's Journal of the American Medical ... flu seasons. This finding supports recent ...
Other Medicine News:Health News:Effect of Maternal Diet on Colic Among Breastfed Infants 2Health News:Dead Palestinian Boy Saves Lives Of Six Others 2Health News:The Exposure Of Cadmium And Its Effects On Kidneys 2Health News:Palmist Claims to Diagnose Ailments Looking At Your Palm 2Health News:Palmist Claims to Diagnose Ailments Looking At Your Palm 3
Gamma GT (Modified IFCC)
Triglycerides GPO-PAP (DIMENSION®)
Triglycerides
Creatine Kinase (CK-MB) Control
Medicine Products: